Bought Generic Drugs In MD? You Could Be Owed Money

BALTIMORE, MD — Marylanders who bought certain generic prescription drugs between May 2009 and December 2019 could be eligible for money from settlements totaling about $96.5 million, according to Maryland Attorney General Anthony Brown.

Consumers are being encouraged to check whether medications they purchased are included in the settlements and submit a claim if they qualify. The settlements involve generic drug manufacturers Glenmark, Lannett, Bausch, Apotex, Heritage and Heritage's parent company, Emcure.

The settlements stem from claims by Maryland and dozens of other states and territories that drug manufacturers colluded to raise the prices of certain generic medications.

"These drug companies unlawfully conspired to drive up the price of generic drugs, forcing Marylanders to pay more for medications they depend on," Brown said. "My office is urging everyone who purchased one of these drugs to check their eligibility for compensation under each of these settlements."

Who Could Get Money?

Consumers may qualify if they purchased one of the generic drugs covered by the settlements between May 2009 and December 2019.

The U.S. District Court for the District of Connecticut this month gave preliminary approval to a plan for distributing settlement money to eligible consumers.

People can check the list of covered medications and file a claim at AGGenericDrugs.com. Questions about eligibility can also be directed to 1-866-290-0182 or info@AGGenericDrugs.com.

The settlements are part of a broader series of cases brought by states over alleged price-fixing in the generic drug industry. Those cases date to 2016 and involve numerous drug manufacturers, executives and medications.

Additional cases remain pending, including allegations involving dozens of topical generic medications.